Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Gilead Sciences: A Biotech No More
Seeking Alpha
Thursday, April 23, 2009 - 9:26am
tags:
Gilead Sciences, biotech
Pay for Performance for Prescription Drugs (Or Maybe Not)
WSJ Online
Thursday, April 23, 2009 - 9:22am
tags:
Januvia, Cigna, Merck, diabetes
Teva acquisition rumor pushes Watson trade
Globes,Israel
Thursday, April 23, 2009 - 8:31am
tags:
Teva Pharmaceuticals, Watson Pharmaceuticals, buyouts
Bristol-Myers, AstraZeneca drug approval delayed
Marketwatch
Thursday, April 23, 2009 - 8:26am
tags:
Bristol-Myers Squibb, FDA, AstraZeneca, Onglyza, diabetes
Sanofi-Aventis CEO: China key for future growth
Yahoo/AP
Thursday, April 23, 2009 - 6:49am
tags:
China, Pharma CEOs, Sanofi, Chris Viehbacher
Novartis posts 14 percent drop in 1Q profit
Yahoo/AP
Thursday, April 23, 2009 - 6:48am
tags:
Novartis, earnings
Icahn, Amylin fail to on settlement in proxy fight
Yahoo/AP
Wednesday, April 22, 2009 - 9:14pm
tags:
Carl Icahn, Amylin, Eli Lilly
Lilly: Court blocks Teva's generic Evista
Marketwatch
Wednesday, April 22, 2009 - 9:12pm
tags:
Teva Pharmaceuticals, Eli Lilly, generics, Evista
Baxter A Healthy Healthcare Holding
Investopedia
Wednesday, April 22, 2009 - 5:12pm
tags:
Baxter International
Report: Drug sales to fall in US, slow elsewhere
Yahoo/AP
Wednesday, April 22, 2009 - 4:08pm
tags:
drug sales
Official: FDA to OK Plan B for 17-year-olds
Google/AP
Wednesday, April 22, 2009 - 3:50pm
tags:
FDA, birth control, Plan B contraceptive, Teva Pharmaceuticals
Illumina shares fall following 1Q results
Yahoo/AP
Wednesday, April 22, 2009 - 3:42pm
tags:
Illumina, earnings
5-Star Stocks Poised to Pop: Forest Labs
Motley Fool
Wednesday, April 22, 2009 - 3:31pm
tags:
Forest Labs
Does Avastin Trial Mean Roche Paid Too Much for Genentech?
WSJ Online
Wednesday, April 22, 2009 - 11:27am
tags:
Roche, cancer, Genentech, drug trials, Avastin
Elan CEO says favors big pharma tie-up
Reuters
Wednesday, April 22, 2009 - 11:26am
tags:
Elan, M&A, Kelly Martin
Amylin: A Discounted Option on Byetta's Outcome
Seeking Alpha
Wednesday, April 22, 2009 - 11:25am
tags:
Amylin, diabetes, Byetta
Amgen Earnings: This May Hurt
TheStreet.com
Wednesday, April 22, 2009 - 11:22am
tags:
Amgen, earnings
Genzyme's profit rises in first quarter
Marketwatch
Wednesday, April 22, 2009 - 9:46am
tags:
Genzyme, earnings
Gilead Beat, Pure and Simple
TheStreet.com
Wednesday, April 22, 2009 - 9:44am
tags:
Gilead Sciences, earnings
Watson Options Trade on Merger Rumors
TheStreet.com
Wednesday, April 22, 2009 - 9:39am
tags:
Watson Pharmaceuticals, M&A, Teva Pharmaceuticals

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.